Rebecca B. Perkins, MD, MSc, 1 Richard S. Guido, MD, 2 Philip E. Castle, PhD, 3 David
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …

Objective To manage cervical screening abnormalities, the 2019 ASCCP management
consensus guidelines will recommend clinical action on the basis of risk of cervical …

Objective The 2019 American Society for Colposcopy and Cervical Pathology Risk-Based
Management Consensus Guidelines for the management of cervical cancer screening …

ABSTRACT A group of 47 experts representing 23 professional societies, national and
international health organizations, and federal agencies met in Bethesda, MD, September …

Cervical cancer can be prevented through routine screening and follow-up of abnormal
results. Several guidelines have been published in the last 4 years from various medical …

Abstract The American Cancer Society (ACS) released updated cervical cancer screening
guidelines in 2020 that endorse a shift in practice to primary human papillomavirus (HPV) …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Objective. To provide revised evidence-based consensus guidelines for managing women
with abnormal cervical cancer screening test results. Participants. A group of 146 experts …

BACKGROUND In the United States, human papillomavirus (HPV) and Papanicolaou (Pap)
testing (cotesting) for cervical screening in women ages 30 to 65 years is the preferred …

Screening in women has decreased the incidence and mortality of cervical cancer.
Precancerous cervical lesions (cervical intraepithelial neoplasias) and cervical carcinomas …